Published in Am J Hum Genet on October 02, 2014
Quantifying prion disease penetrance using large population control cohorts. Sci Transl Med (2016) 3.04
Genetic Prion Disease Caused by PRNP Q160X Mutation Presenting with an Orbitofrontal Syndrome, Cyclic Diarrhea, and Peripheral Neuropathy. J Alzheimers Dis (2016) 0.75
Prions. Proc Natl Acad Sci U S A (1998) 27.80
Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med (2012) 14.14
Heritability in the genomics era--concepts and misconceptions. Nat Rev Genet (2008) 13.42
Trinucleotide repeat disorders. Annu Rev Neurosci (2007) 9.45
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol (1999) 6.98
Unconventional viruses and the origin and disappearance of kuru. Science (1977) 6.38
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain (2009) 5.03
Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet (2004) 4.63
"Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet (1992) 3.74
Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome. Exp Neurol (1989) 3.00
Rapidly progressive dementia. Ann Neurol (2008) 3.00
Genetic prion disease: the EUROCJD experience. Hum Genet (2005) 2.64
Repeat expansion disease: progress and puzzles in disease pathogenesis. Nat Rev Genet (2010) 2.36
Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. N Engl J Med (1991) 2.05
Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain (2004) 1.96
Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang (2006) 1.76
Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet (1999) 1.74
Aminoacid polymorphism in human prion protein and age at death in inherited prion disease. Lancet (1991) 1.67
Rapidly progressive dementia. Neurol Clin (2007) 1.58
First symptom in sporadic Creutzfeldt-Jakob disease. Neurology (2006) 1.58
Molecular genetics of human prion diseases in Germany. Hum Genet (1999) 1.53
Genetic anticipation is associated with telomere shortening in hereditary breast cancer. PLoS Genet (2011) 1.51
Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology (2014) 1.47
Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia. Lancet (1990) 1.44
Ten years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's Disease Prediction Consortium. J Med Genet (2000) 1.35
Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease (CJD). Am J Hum Genet (1993) 1.34
Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan origin. Lancet (1990) 1.27
The risk of developing Creutzfeldt-Jakob disease in subjects with the PRNP gene codon 200 point mutation. Neurology (1994) 1.25
DNA analysis of Huntington's disease: five years of experience in Germany, Austria, and Switzerland. Neurology (1999) 1.22
Complete penetrance of Creutzfeldt-Jakob disease in Libyan Jews carrying the E200K mutation in the prion protein gene. Mol Med (1995) 1.19
Preliminary evidence for anticipation in genetic E200K Creutzfeldt-Jakob disease. Neurology (1999) 1.17
Presymptomatic testing in Huntington's disease and autosomal dominant cerebellar ataxias. Neurology (2002) 1.13
Family and molecular data for a fine analysis of age at onset in Huntington disease. Am J Med Genet (2000) 1.10
Uptake of Huntington disease predictive testing in a complete population. Clin Genet (2010) 1.07
PRNP allelic series from 19 years of prion protein gene sequencing at the MRC Prion Unit. Hum Mutat (2010) 1.07
Loss of glycosylation associated with the T183A mutation in human prion disease. Acta Neuropathol (2004) 1.06
Transmissible spongiform encephalopathies in humans. Annu Rev Microbiol (1999) 1.04
Human prion diseases in the United States. PLoS One (2010) 1.03
Differential diagnosis of Jakob-Creutzfeldt disease. Arch Neurol (2012) 0.98
Testing for age-at-onset anticipation with affected parent-child pairs. Biometrics (1999) 0.93
Age-at-interview bias in anticipation studies: computer simulations and an example with panic disorder. Psychiatr Genet (1996) 0.93
A review of statistical methods for testing genetic anticipation: looking for an answer in Lynch syndrome. Genet Epidemiol (2010) 0.93
Statistical pitfalls in detecting age-of-onset anticipation: the role of correlation in studying anticipation and detecting ascertainment bias. Psychiatr Genet (1995) 0.87
The problem of anticipation in pedigrees of dystrophia myotonica. Ann Eugen (1948) 0.85
Predictive and pre-natal testing for Huntington Disease in Australia: results and challenges encountered during a 10-year period (1994-2003). Clin Genet (2006) 0.85
Failure to detect the presence of prions in the uterine and gestational tissues from a Gravida with Creutzfeldt-Jakob disease. Am J Pathol (2009) 0.85
Statistical evaluation of age-at-onset anticipation: a new test and evaluation of its behavior in realistic applications. Am J Hum Genet (1998) 0.85
New simple tests for age-at-onset anticipation: application to panic disorder. Genet Epidemiol (2005) 0.84
Creutzfeldt-Jakob disease in Australia 1970-1999. Neurology (2002) 0.82
Is there evidence of vertical transmission of variant Creutzfeldt-Jakob disease? J Neurol Neurosurg Psychiatry (2009) 0.82
Clinical aspects of common genetic Creutzfeldt-Jakob disease. Eur J Epidemiol (2012) 0.79
Predictive testing for inherited prion disease: report of 22 years experience. Eur J Hum Genet (2014) 0.79
Age at Death of Creutzfeldt-Jakob disease in subsequent family generation carrying the E200K mutation of the prion protein gene. PLoS One (2013) 0.77